Medical Patent News

RSS

Affiris GmbH granted a Europe-wide patent for key elements of its Alzheimer's vaccine

As a result, the company has exclusive rights of use to the peptide sequences for an innovative approach to vaccine development. The tolerability of the first Affiris vaccine, AFFITOPE AD01, is currently being tested as part of a phase I clinical trial. The lead investor in the company, MIG-Fonds, is extremely satisfied with the expanding patent portfolio of Affiris GmbH.

21 Nov 2007

Nanogen reissued patent for diagnosis of chronic congestive heart failure

Nanogen, Inc. has announced that it has been granted U.S. Patent No. RE39,816, which is a reissue of United States Patent No. 6,461,828, titled, "Conjunctive Analysis of Biological Marker Expression For Predicting Cardiac Mortality".

19 Nov 2007

Morphotek issued new U.S patent for method to enhance the affinity of monoclonal antibodies

Morphotek, Inc., a subsidiary of Eisai Co., Ltd. has announced the issuance of United States Patent No. 7,235,643 B2 (the "643" patent).

19 Nov 2007

Avicena receives U.S. patent for compounds to treat Lou Gehrig's disease

Avicena Group, Inc. has announced that the United States Patent and Trademark Office (USPTO) has granted the Company U.S. Patent #7,285,573 for the use of the Company's proprietary drug candidates for the treatment of amyotrophic lateral sclerosis ("ALS" or "Lou Gehrig's Disease").

14 Nov 2007

Foamix issued cosmetic and pharmaceutical foam patent approvals

Foamix Ltd., a leading developer of topical foam products for dermatology, gynecology and skin-care, has been awarded a New Zealand patent and four South African patents related to the Company's proprietary foam technology.

14 Nov 2007

CellCyte Genetics receives patent on stem cell delivery method

CellCyte Genetics Corporation has announced that is has received notice of the issuance of a U.S. patent (U.S. Patent No. 7,282,222) for its unique methods and compositions approach to deliver and direct stem cells to target organs in the body.

13 Nov 2007

Microcarrier patent to be auctioned

Sedum Laboratories, Inc., formerly of Mansfield, Mass., is auctioning its U.S. Patent #6,645,525 titled "Ionically Formulated Biomolecule Microcarriers."

6 Nov 2007

Barr confirms patent challenge of Ritalin LA

Barr Pharmaceuticals, Inc. has confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by Novartis Pharmaceuticals Corporation in connection with its Ritalin LA (methylphenidate hydrochloride) extended-release capsules, 10mg, 20mg, 30mg and 40mg.

5 Nov 2007

Boston Scientific announces verdict in Cordis patent case

Boston Scientific Corporation has announced that a jury in U.S. District Court in San Francisco has found that Boston Scientific infringes a patent of Cordis Corporation, a subsidiary of Johnson & Johnson, under the doctrine of equivalents.

1 Nov 2007

Nventa Biopharmaceuticals receives new U.S. patent

Nventa Biopharmaceuticals Corporation has announced that the U.S. Patent and Trademark Office has issued Patent Number 7,262,014 to Nventa covering compositions and methods for inducing or enhancing immune responses to a human papillomavirus (HPV) antigen with or without the use of an adjuvant.

29 Oct 2007

Gene screen patent brings 2007 Deal of Distinction Award to UChicagoTech

UChicagoTech, the University of Chicago's Office of Technology and Intellectual Property, has received a 2007 Deal of Distinction Award from the Licensing Executives Society of U.S.A. and Canada.

29 Oct 2007

Sigma-Aldrich and Oxford BioMedica win key ruling in Open Biosystems patent case

Sigma-Aldrich and Oxford BioMedica have announced that they received a key order confirming the strength and validity of intellectual property owned by Oxford BioMedica and licensed exclusively in the research field to Sigma-Aldrich.

25 Oct 2007

Illumina named as defendant in patent infringement suits

Illumina, Inc. (NASDAQ:ILMN) released the following statement by Jay Flatley, its Chief Executive Officer, in response to new patent infringement suits filed yesterday by Affymetrix in Delaware, the United Kingdom and Germany. As of this time, Illumina has yet to be served with these suits.

From Illumina, Inc. 25 Oct 2007

Mylan settles Paroxetine Hydrochloride patent license with GlaxoSmithKline

Mylan Inc. has announced that it and its subsidiary Mylan Pharmaceuticals Inc. have entered into a patent license and settlement agreement with GlaxoSmithKline (GSK) relating to Paroxetine Hydrochloride (HCl) Extended-release (ER) Tablets, the generic version of GSK's Paxil CR.

24 Oct 2007

New method of oral insulin delivery patented

Syracuse University researchers have designed, tested and patented a new method of oral insulin delivery that can potentially help reduce daily insulin injections for millions of people with diabetes who require therapy for optimal glycemic control.

22 Oct 2007

Microbix Biosystems granted U.S. patent for its influenza vaccine

Microbix Biosystems Inc. has been granted a patent by the U.S. Patent Office for its technology - VIRUSMAX - which enables vaccine manufacturers to double the amount of influenza vaccine they produce each year.

22 Oct 2007

Adenoscan patent lawsuits settled

Astellas Pharma Inc., King Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Ltd. have announced that U.S. subsidiaries of Astellas, along with Item Development AB and King have executed settlement agreements with one of Teva's subsidiaries on lawsuits filed in the United States against Teva's subsidiaries regarding their submission of an abbreviated new drug application (ANDA) for a generic version of Adenoscan (adenosine injection), a pharmacologic stress agent.

22 Oct 2007

Accelr8 announces patent allowance for rapid bacterial diagnostic method

Accelr8 Technology Corporation has announced that it received notice of allowance on the first patent related to its BACcel rapid diagnostic platform.

19 Oct 2007

Health Discovery receives notice of allowance of U.S. patent application covering kernel selection methods

Health Discovery Corporation has announced that the U.S. Patent and Trademark Office has issued a notice of allowance of HDC's patent application covering methods for selection of kernels, i.e., functions or algorithms that are used to transform input data into a different configuration, known as "feature space", which allows for easier recognition of patterns within the data.

18 Oct 2007

CryoCath files patent infringement lawsuit

CryoCath Technologies Inc., the global leader in cardiac arrhythmia products to treat cardiovascular disease, today announced it filed against CryoCor, Inc. a patent infringement lawsuit in the United States District Court for the District of Delaware.

17 Oct 2007